At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9 enrolled
Drug / intervention
Erchonia EVRLdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Evaluation of the Effect of the Erchonia® EVRL OTC™ for the Relief of Diabetic Peripheral Neuropathy Foot Pain
In Brief
A clinical study evaluating Erchonia EVRL for Neuropathy. Completed, enrolled 9 participants across 1 site.
Detailed Summary
This study is to see if applying red and violet low-level laser light can help to reduce foot pain associated with diabetic peripheral neuropathy,
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsNeuropathy
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
20222023202420252026
Enrollment StartJun 2021
First PostedOct 2021
Primary CompletionDec 2021
TodayJul 2026
First PostedOct 25, 2021
Enrollment StartJun 16, 2021
Primary CompletionDec 1, 2021
TodayJul 2, 2026
Enrollment to primary: 6 monthsPosted 4.7 years ago
Interventions
Erchonia EVRLdevice
42 procedure administrations with the Erchonia® EVRL™ administered by the subject at home: Twice daily procedure administrations for 3 weeks.